374 related articles for article (PubMed ID: 34546296)
1. A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement.
Lee H; Cashin AG; Lamb SE; Hopewell S; Vansteelandt S; VanderWeele TJ; MacKinnon DP; Mansell G; Collins GS; Golub RM; McAuley JH; ; Localio AR; van Amelsvoort L; Guallar E; Rijnhart J; Goldsmith K; Fairchild AJ; Lewis CC; Kamper SJ; Williams CM; Henschke N
JAMA; 2021 Sep; 326(11):1045-1056. PubMed ID: 34546296
[TBL] [Abstract][Full Text] [Related]
2. Development of A Guideline for Reporting Mediation Analyses (AGReMA).
Cashin AG; McAuley JH; Lamb SE; Hopewell S; Kamper SJ; Williams CM; Henschke N; Lee H
BMC Med Res Methodol; 2020 Feb; 20(1):19. PubMed ID: 32013883
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
[TBL] [Abstract][Full Text] [Related]
5. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.
Gates M; Gates A; Pieper D; Fernandes RM; Tricco AC; Moher D; Brennan SE; Li T; Pollock M; Lunny C; Sepúlveda D; McKenzie JE; Scott SD; Robinson KA; Matthias K; Bougioukas KI; Fusar-Poli P; Whiting P; Moss SJ; Hartling L
BMJ; 2022 Aug; 378():e070849. PubMed ID: 35944924
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
[TBL] [Abstract][Full Text] [Related]
8. Advancing the reporting of mechanisms in implementation science: A guideline for reporting mediation analyses (AGReMA).
Cashin AG; McAuley JH; Lee H
Implement Res Pract; 2022; 3():26334895221105568. PubMed ID: 37091093
[TBL] [Abstract][Full Text] [Related]
9. Items for consideration in a reporting guideline for mediation analyses: a Delphi study.
Cashin AG; McAuley JH; Lamb S; Hopewell S; Kamper SJ; Williams CM; Henschke N; Lee H
BMJ Evid Based Med; 2021 Jun; 26(3):106. PubMed ID: 32847804
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
[TBL] [Abstract][Full Text] [Related]
11. Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments.
Elsman EBM; Butcher NJ; Mokkink LB; Terwee CB; Tricco A; Gagnier JJ; Aiyegbusi OL; Barnett C; Smith M; Moher D; Offringa M
Syst Rev; 2022 Jun; 11(1):121. PubMed ID: 35698213
[TBL] [Abstract][Full Text] [Related]
12. Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement.
Skrivankova VW; Richmond RC; Woolf BAR; Yarmolinsky J; Davies NM; Swanson SA; VanderWeele TJ; Higgins JPT; Timpson NJ; Dimou N; Langenberg C; Golub RM; Loder EW; Gallo V; Tybjaerg-Hansen A; Davey Smith G; Egger M; Richards JB
JAMA; 2021 Oct; 326(16):1614-1621. PubMed ID: 34698778
[TBL] [Abstract][Full Text] [Related]
13. Essential items for reporting of scaling studies of health interventions (SUCCEED): protocol for a systematic review and Delphi process.
Gogovor A; Zomahoun HTV; Ben Charif A; McLean RKD; Moher D; Milat A; Wolfenden L; Prévost K; Aubin E; Rochon P; Ekanmian G; Sawadogo J; Rheault N; Légaré F
Syst Rev; 2020 Jan; 9(1):11. PubMed ID: 31926555
[TBL] [Abstract][Full Text] [Related]
14. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
[TBL] [Abstract][Full Text] [Related]
15. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
[TBL] [Abstract][Full Text] [Related]
16. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
[TBL] [Abstract][Full Text] [Related]
17. Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement.
Kahan BC; Hall SS; Beller EM; Birchenall M; Chan AW; Elbourne D; Little P; Fletcher J; Golub RM; Goulao B; Hopewell S; Islam N; Zwarenstein M; Juszczak E; Montgomery AA
JAMA; 2023 Dec; 330(21):2106-2114. PubMed ID: 38051324
[TBL] [Abstract][Full Text] [Related]
18. Protocol for the development of a reporting guideline for causal and counterfactual prediction models in biomedicine.
Xu J; Guo Y; Wang F; Xu H; Lucero R; Bian J; Prosperi M
BMJ Open; 2022 Jun; 12(6):e059715. PubMed ID: 35725267
[TBL] [Abstract][Full Text] [Related]
19. Protocol for the development of a reporting guideline for umbrella reviews on epidemiological associations using cross-sectional, case-control and cohort studies: the Preferred Reporting Items for Umbrella Reviews of Cross-sectional, Case-control and Cohort studies (PRIUR-CCC).
Solmi M; Cobey K; Moher D; Ebrahimzadeh S; Dragioti E; Shin JI; Radua J; Cortese S; Shea B; Veronese N; Hartling L; Pollock M; Egger M; Papatheodorou S; Ioannidis JP; Carvalho AF
BMJ Open; 2024 Jun; 14(6):e071136. PubMed ID: 38889936
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
Orkin AM; Gill PJ; Ghersi D; Campbell L; Sugarman J; Emsley R; Steg PG; Weijer C; Simes J; Rombey T; Williams HC; Wittes J; Moher D; Richards DP; Kasamon Y; Getz K; Hopewell S; Dickersin K; Wu T; Ayala AP; Schulz KF; Calleja S; Boutron I; Ross JS; Golub RM; Khan KM; Mulrow C; Siegfried N; Heber J; Lee N; Kearney PR; Wanyenze RK; Hróbjartsson A; Williams R; Bhandari N; Jüni P; Chan AW;
JAMA; 2021 Jul; 326(3):257-265. PubMed ID: 34152382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
